18[F]FDG-PET/CT is a Useful Molecular Marker in Evaluating Tumour Aggressiveness: A Revised Understanding of an In-Vivo FDG-PET Imaging that Alludes the Alteration of Cancer Biology
暂无分享,去创建一个
F. Fathinul | A. J. Nordin | W. F. E. Lau | W. F. Lau | A. Nordin | F. Fathinul | Abdul Jalil Nordin | W. Lau
[1] Sigrid Stroobants,et al. The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer , 2007 .
[2] H. Abdel-Nabi,et al. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules. , 2008, Journal of hematology & oncology.
[3] J. Talbot,et al. Prospective Comparison of FDG and FET PET/CT in Patients with Head and Neck Squamous Cell Carcinoma , 2008, Molecular Imaging and Biology.
[4] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[5] J M Hoffman,et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] S. Shiono,et al. Positron Emission Tomography/Computed Tomography and Lymphovascular Invasion Predict Recurrence in Stage I Lung Cancers , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[7] V Kalff,et al. The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] W. Brenner,et al. Risk assessment in liposarcoma patients based on FDG PET imaging , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[9] Guido Kroemer,et al. Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.
[10] Philip Smith,et al. Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.
[11] A. Alavi,et al. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] Seong-Jang Kim,et al. Open Access RESEARCH , 2010 .
[13] S. Larson,et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Andrew Homb,et al. 18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation , 2011, The Journal of Nuclear Medicine.
[15] S. Larson,et al. 18F-FDG PET Scanning Correlates with Tissue Markers of Poor Prognosis and Predicts Mortality for Patients After Liver Resection for Colorectal Metastases , 2007, Journal of Nuclear Medicine.
[16] K. Kinzler,et al. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.
[17] M. Younes,et al. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[18] Lijuan Yu,et al. Correlation of 18F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer , 2009, Nuclear medicine communications.
[19] G. Semenza,et al. HIF-1 and tumor progression: pathophysiology and therapeutics. , 2002, Trends in molecular medicine.
[20] J. Nährig,et al. Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] M. Dewhirst,et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.
[22] C. Perry,et al. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours. , 2003, Drugs.
[23] C. Van de Wiele,et al. FDG uptake, a surrogate of tumour hypoxia? , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[24] J. Choi,et al. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] H. Jun,et al. Recent advances in insulin gene therapy for type 1 diabetes. , 2002, Trends in molecular medicine.
[26] Philippe Lambin,et al. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. , 2007, European journal of cancer.
[27] C. Graham,et al. Nitric oxide‐mediated regulation of hypoxia‐induced B16F10 melanoma metastasis , 2004, International journal of cancer.
[28] Jeffrey S. Morris,et al. Epigenetic-Genetic Interactions in the APC/WNT, RAS/RAF, and P53 Pathways in Colorectal Carcinoma , 2008, Clinical Cancer Research.
[29] J. Nährig,et al. Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] C. Hong,et al. Prognostic Value of Primary Tumor Uptake on F-18 FDG PET/CT in Patients with Invasive Ductal Breast Cancer , 2011, Nuclear medicine and molecular imaging.
[31] Sang Moo Lim,et al. Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats. , 2009, Nuclear medicine and biology.
[32] Y. Ishigaki,et al. VEGF-A and its isoform VEGF121 mRNA expression measured by quantitative real-time RT-PCR: correlation with F-18 FDG uptake and aggressiveness of lung adenocarcinoma: preliminary study , 2011, Annals of nuclear medicine.
[33] Dwight E Heron,et al. PET-CT in Radiation Oncology: The Impact on Diagnosis, Treatment Planning, and Assessment of Treatment Response , 2008, American journal of clinical oncology.
[34] A. Kjaer,et al. F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors , 2010 .
[35] P. Leder,et al. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.
[36] Jane Bayani,et al. Genomic mechanisms and measurement of structural and numerical instability in cancer cells. , 2007, Seminars in cancer biology.
[37] Adrian L Harris,et al. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. , 2006, Cancer research.
[38] D. Tuveson,et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. , 2001, The New England journal of medicine.
[39] A. Folpe,et al. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.